We commend Xia et al1 for their ambitious cluster randomized trial evaluating the impact of endoscopic screening on upper gastrointestinal (UGI) cancer mortality. The study provides critical evidence for population-based screening strategies. However, several methodologic and interpretative limitations undermine the validity of the conclusions and warrant urgent clarification.
We will be happy to hear your thoughts